Who really profits when children are diagnosed with gender dysphoria? In this explosive episode, we uncover the billion-dollar transgender medical industry—from puberty blockers and hormone therapies to surgeries and lifelong treatments. Follow the money trail and discover how powerful institutions, pharmaceutical companies, and medical providers are fueling one of the fastest-growing sectors in healthcare. Is this about compassion and care, or about cash and control? Join Jillian Michaels and Chris Moritz as they break down the economics, expose the incentives, and ask the tough questions no one else will.